Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : EntreMed (ENMD) -- Ignore unavailable to you. Want to Upgrade?

To: Fred Zhang who wrote (1952)	7/23/1999 9:12:00 PM
From: tommysdad	Read Replies (2) \| Respond to of 2135

<<Go ask any top notch scientists in biomedical fields, they could tell you that EntreMed's approach(developed by Dr. Folkman's lab) is the one and only to cure cancer effectively. >> That is a very interesting statement. I know lots of biologists whom I consider to be top-notch scientists. None of them (0%) have invested in ENMD. None believes this is the one and only (way?) to cure cancer effectively. Many think it's an interesting approach with lots of merit, but not a cure-all. Many have invested in other companies developing other cancer treatments. Are they then not "top-notch scientists" according to you? Or was yours simply an over-blown statement with no basis in fact? Are all the cancer researchers who are not working at EntreMed or in Folkman's lab or on angiogenesis inhibitors simply wasting their time and careers? I think not. I hope ENMD cures cancer, I really do. But in humans, not in mice.